A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol
A Randomized, Multiple-Dose, Placebo-Controlled, Multi-Center Study Comparing Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg to QVAR® 40 mcg (Beclomethasone Dipropionate HFA), Inhalation Aerosol in Treatment of Subjects With Asthma
Sponsor: Amneal Ireland Limited
Terminated
Insufficient investigational product
Listed as NCT03562949, this PHASE3 trial focuses on Asthma and remains terminated or withdrawn. Sponsored by Amneal Ireland Limited, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Terminated PHASE3
Status: Not Yet Recruiting → Terminated
-
Jul 2018 — Feb 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Amneal Ireland Limited
For direct contact, visit the study record on ClinicalTrials.gov .